Mirion Technologies, Inc.

Mirion Technologies, Inc.

MIR

$16.49

Updated: 23/09/2026, 03:12:45

Market Cap
$4.01B
Sector
Industrials
Industry
Industrial - Machinery
Country
US
Stock valuation chart
One-year closing share-price history for MIR
Company Profile

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

USD
NYSE
CEO: Thomas D. Logan
Employees: 3,281
https://www.mirion.com
Asset Summaries
Latest generated summaries for MIR

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for MIR.
Share price
$16.49
Market cap
$4.01B
Exchange
NYSE
Currency
USD
CEO
Thomas D. Logan
Employees
3,281
IPO date
20/08/2020
Beta
1.054
Last dividend
$0.00
Day range
$16.07 – $16.68
52-week range
$14.11 – $30.28
1-day performance
1.73%
1-year performance
16.87%
Current drawdown (1Y)
-45.54%
CIK
0001809987
CUSIP
60471A101
ISIN
US60471A1016
Created
07/12/2025, 05:15:10
Last update
23/09/2026, 03:12:45

Track Mirion Technologies, Inc. with an AI analyst

See which prediction-market events move MIR, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.